A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder

1.

Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148-158.

2.

Kokame K, Zheng X, Sadler JE. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin

and is inhibited competitively by protein C. J Biol Chem. 1998;273(20):12135-12139.

3.

Okamoto T, Tanigami H, Suzuki K, Shimaoka M. Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis. Crit Care Res

Pract. 2012;2012:614545.

4.

Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 1990;75(2):329-336.

5.

Ito T, Kakihana Y, Maruyama I. Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases. Expert Opin Ther Targets.

2016;20(2):151-158.

6.

Griffin JH, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012;95(4):333-345.

7.

Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and

factor V activation. J Biol Chem. 1982;257(14):7944-7947.

8.

Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombinthrombomodulin complex. J Biol Chem. 1996;271(28):16603-16608.

9.

Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost. 2003;1(7):1515-1524.

10. Isermann B, Hendrickson SB, Hutley K, Wing M, Weiler H. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulindeficient mice from early lethality and reveals a secondary developmental block. Development. 2001;128(6):827-838.

11. Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before

development of a functional cardiovascular system. Proc Natl Acad Sci USA. 1995;92(3):850-854.

12. Weiler H, Lindner V, Kerlin B, et al. Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol. 2001;21(9):

1531-1537.

13. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA. Thrombomodulin gene mutations associated with myocardial infarction. Circulation. 1997;96(1):

15-18.

14. Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(4):345-357.

15. Demeulenaere M, Devreese K, Vanbelleghem H, et al. Thrombomodulin and endothelial dysfunction: A disease-modifier shared between malignant

hypertension and atypical hemolytic uremic syndrome. Nephron. 2018;140(1):63-73.

16. Mohri M. ART-123:Recombinant human soluble thrombomodulin. Cardiovasc Drug Rev. 2006;18(4):312-325.

17. Vincent JL, Francois B, Zabolotskikh I, et al; SCARLET Trial Group. Effect of a recombinant human soluble thrombomodulin on mortality in patients with

sepsis associated coagulopathy: The SCARLET randomized clinical trial. JAMA. 2019;321(20):1993-2002.

18. Ito T, Kawahara K, Okamoto K, et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler

Thromb Vasc Biol. 2008;28(10):1825-1830.

19. Karczewski KJ, Francioli LC, Tiao G, et al; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in

141,456 humans [published correction appears in Nature. 2021;590(7846):E53]. Nature. 2020;581(7809):434-443.

20. Ito T, Thachil J, Asakura H, Levy JH, Iba T. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted

anticoagulant protein with therapeutic potential. Crit Care. 2019;23(1):280.

12 OCTOBER 2021 • VOLUME 5, NUMBER 19

THROMBOMODULIN GENE VARIANT CAUSING BLEEDING

3837

Downloaded from http://ashpublications.org/bloodadvances/article-pdf/5/19/3830/1824848/advancesadv2020003814.pdf by guest on 28 December 2021

Authorship

21. Fuentes-Prior P, Iwanaga Y, Huber R, et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature. 2000;404(

6777):518-525.

22. Wood MJ, Sampoli Benitez BA, Komives EA. Solution structure of the smallest cofactor-active fragment of thrombomodulin. Nat Struct Biol. 2000;7(3):

200-204.

23. Wang W, Nagashima M, Schneider M, Morser J, Nesheim M. Elements of the primary structure of thrombomodulin required for efficient thrombinactivable fibrinolysis inhibitor activation. J Biol Chem. 2000;275(30):22942-22947.

24. Weiler-Guettler H, Christie PD, Beeler DL, et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin

Invest. 1998;101(9):1983-1991.

25. Isermann B, Hendrickson SB, Zogg M, et al. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and

causes juvenile-onset thrombosis. J Clin Invest. 2001;108(4):537-546.

27. Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9(3):331337.

28. Jamal A, Mesdaghinia S. Ruptured corpus luteum cysts and anticoagulant therapy. Int J Gynaecol Obstet. 2002;76(3):319-320.

29. Cheng Y, Kawamura K, Deguchi M, Takae S, Mulders SM, Hsueh AJ. Intraovarian thrombin and activated protein C signaling system regulates

steroidogenesis during the periovulatory period. Mol Endocrinol. 2012;26(2):331-340.

30. Okada M, Tominaga N, Honda G, et al. A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI

activation. Blood Adv. 2020;4(12):2631-2639.

31. Langdown J, Luddington RJ, Huntington JA, Baglin TP. A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin

(p.Cys537Stop). Blood. 2014;124(12):1951-1956.

32. Morrow GB, Beavis J, Harper S, Bignell P, Laffan MA, Curry N. Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and

evaluation of therapeutic strategies to manage the rare bleeding phenotype. Thromb Res. 2021;197:100-108.

3838

OSADA et al

12 OCTOBER 2021 • VOLUME 5, NUMBER 19

Downloaded from http://ashpublications.org/bloodadvances/article-pdf/5/19/3830/1824848/advancesadv2020003814.pdf by guest on 28 December 2021

26. van Mens TE, Liang HH, Basu S, et al. Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd

gene inactivation. Blood Adv. 2017;1(15):1148-1158.

...